UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000023033
Receipt No. R000026545
Official scientific title of the study Effect of collagen peptide intake on the leg pain onset in the training phase of long-distance runners
Date of disclosure of the study information 2016/07/07
Last modified on 2017/02/03 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of collagen peptide intake on the leg pain onset in the training phase of long-distance runners
Title of the study (Brief title) The effect of collagen intake for long-distance runners
Region
Japan

Condition
Condition Healthy long-distance runners
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aims to reveal whether Collagen Peptide that has reduce suppressive and symptoms of leg pain in athletes.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase

Assessment
Primary outcomes JKOM Score
Key secondary outcomes 1. Anthropometric (height, weight, upper arm perimeter, triceps subcutaneous fat thickness, biceps subcutaneous fat thickness, fat thickness under the shoulder blades, thigh perimeter, anterior thigh fat thickness, BMI, body fat mass, blood pressure)
2. Diet survey (using a self-administered diet history questionnaire with a validity study in Japanese, to assess energy, nutrients such as protein, meat, fish, the intake of food groups, such as beverages)
3. Lifestyle survey (smoking habits, sleep habits, physical activity status, to evaluate exercise history, medical history, medication situation, the presence or absence of a food allergy)
4. Blood tests (general blood test item, inflammation-related marker, to measure the blood levels of the tissue matrix metabolic-related biomarkers)
5. Ultrasonic echo test (to measure the tissue thickness, such as the Achilles tendon and plantar fascia)
6. Activity Survey (for training, such as mileage, ingestion situation of the test diet, to record the therapeutic situation for the leg pain)
7. Occurrence of leg pain (1 year) (the affected area and symptoms, the treatment method, recording the time it took to return)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intervention: Intake 5g collagen peptide for 60 days
Interventions/Control_2 Control: Intake 5g Dextrin for 60days
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria - Over 18 years old
- Male
- People who constantly train with mechanical stress
Key exclusion criteria That apply to one or more are excluded from the subject of the present study.
1. who is diabetes or abnormalities in diabetes or HbA1c
2. who has a serious disease history
3. who shows the abnormal values of liver and kidney function
4.who shows a failure in cardiopulmonary function
5. who has a food allergy to pork and gelatin
6. who undergone the surgery of the digestive tract
7. who was diagnosed with chronic or acute infection by physician's discretion
8. who is participating in other clinical trials at the start of the study
9. who continually ingest collagen within the past 3 months
10. who has a continuous intake of supplements for the purpose of joint pain improved within the past 3 months
11. who was determined as the inappropriate by investigators
12. who is smoker
13. who has habit of taking excessive alcohol
Target sample size 60

Research contact person
Name of lead principal investigator Hiroshi Mano
Organization Josai University
Division name Faculty of Pharmaceutical Sciences Department of Clinical Dietetics and Human Nutrition
Address 1-1, Keyakidai, Sakado, Saitama, Japan
TEL 049-271-7246
Email h-mano@josai.ac.jp

Public contact
Name of contact person Hiroshi Mano
Organization Josai University
Division name Faculty of Pharmaceutical Sciences Department of Clinical Dietetics and Human Nutrition
Address 1-1, Keyakidai, Sakado, Saitama, Japan
TEL 049-271-7246
Homepage URL
Email h-mano@josai.ac.jp

Sponsor
Institute Nitta Gelatin Inc. Peptide Division.
Institute
Department

Funding Source
Organization Nitta Gelatin Inc.
Peptide Division.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Saitama Medical University
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 城西大学(埼玉県)(Josai University, Saitama)

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 04 Month 25 Day
Anticipated trial start date
2016 Year 07 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 05 Day
Last modified on
2017 Year 02 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026545